E. Gore

E. Gore, N. Choong, A. Currey, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prophylactic cranial irradiation for patients with lung cancer.

D. de Ruysscher, B. Slotman, A. Sun, 2016, The Lancet. Oncology.

Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck.

A. Garden, C. Jones, J. Cooper, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129.

Christopher U. Jones, K. Ang, R. Weber, 2017, International journal of radiation oncology, biology, physics.

Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung.

L. Wilson, H. Choy, M. Suntharalingam, 2012, International journal of radiation oncology, biology, physics.

Do "elderly fit" patients have less comorbidity?

E. Gore, R. Byhardt, S. Firat, 2003, International journal of radiation oncology, biology, physics.

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Benjamin Movsas, Walter J Curran, Elizabeth Gore, 2011, Journal of the National Cancer Institute.

Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.

H. Choy, B. Movsas, A. Sun, 2013, International journal of radiation oncology, biology, physics.

Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline.

K. Rosenzweig, F. Detterbeck, C. Faivre-Finn, 2020, Practical radiation oncology.

Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.

H. Choy, L. Gaspar, K. Bae, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive‐Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937

R. Hales, P. Iyengar, J. Bradley, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms.

T. Stinchcombe, E. Gore, 2010, The oncologist.

Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data.

M. Kelley, R. Sparapani, E. Gore, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.

Christopher U. Jones, E. Horwitz, T. Pisansky, 2023, European urology.

Prostate‐specific antigen response after short‐term hormone therapy plus external‐beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413

I. Hsu, H. Sandler, M. Roach, 2013, Cancer.

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.

H. Sandler, M. Amin, T. Pisansky, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.

H. Choy, M. Suntharalingam, L. Gaspar, 2019, JAMA oncology.

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.

K. Ang, R. Weber, C. Chung, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy

D. King, E. Gore, C. Johnstone, 2023, Radiation Oncology.

Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.

K. Rosenzweig, W. Curran, H. Choy, 2015, Practical radiation oncology.

Defining a Novel Cardiac Contouring Atlas for NSCLC Using Cadaveric Anatomy

J. Bradley, E. Gore, C. Robinson, 2014 .

Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

P. Iyengar, A. Bezjak, J. Bradley, 2020, International Journal of Radiation Oncology*Biology*Physics.

Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group.

E. Gore, R. Byhardt, S. Firat, 2002, International journal of radiation oncology, biology, physics.

Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non–Small Cell Lung Cancer: NRG Oncology RTOG 0839

B. Loo, M. Diehn, J. Bradley, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group.

Benjamin Movsas, Walter J Curran, Kyounghwa Bae, 2012, International journal of radiation oncology, biology, physics.

Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018.

M. Mehta, F. Schmitt, W. Regine, 2002, International journal of radiation oncology, biology, physics.

Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force.

P. Koper, R. Audisio, I. Kunkler, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.

H. Choy, L. Gaspar, K. Bae, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of the sexual adjustment questionnaire (SAQ) in prostate cancer patients enrolled on radiation therapy oncology group (RTOG) studies 90-20 and 94-08

L. Gaspar, B. Prestidge, G. Hanks, 1998 .

Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review

M. Siker, E. Gore, J. Bovi, 2018, Neurosurgery.

Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.

Christopher U. Jones, J. Torres-Roca, H. Sandler, 2015, International journal of radiation oncology, biology, physics.

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408

Christopher U. Jones, H. Sandler, A. Raben, 2017, Advances in radiation oncology.

PRE-IRRADIATION EVALUATION AND MANAGEMENT OF BRAIN METASTASES

J. Buatti, J. Bradley, I. Germano, 2014 .

Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01.

Christopher U. Jones, R. Mak, H. Sandler, 2016, Urologic oncology.

Muscle endurance, cancer‐related fatigue, and radiotherapy in prostate cancer survivors

E. Gore, M. Montagnini, Alexander Ng, 2011, Muscle & nerve.

Value CMR: Towards a Comprehensive, Rapid, Cost-Effective Cardiovascular Magnetic Resonance Imaging

J. Rubenstein, V. E. Arpinar, E.-S. H. Ibrahim, 2020, medRxiv.

Clinical implementation and initial experience of real-time motion tracking with jaws and MLC during helical tomotherapy delivery.

X. Li, E. Gore, A. Tai, 2021, Practical radiation oncology.

Evaluation and management of elderly patients with lung cancer.

B. Movsas, C. Langer, E. Gore, 2012, Seminars in radiation oncology.

The effects of comorbidity and age on RTOG study enrollment in Stage III non-small cell lung cancer patients who are eligible for RTOG studies.

E. Gore, R. Byhardt, S. Firat, 2010, International journal of radiation oncology, biology, physics.

Age Is Independent of Comorbidity Influencing Patient Selection for Combined Modality Therapy for Treatment of Stage III Nonsmall Cell Lung Cancer (NSCLC)

E. Gore, R. Byhardt, S. Firat, 2006, American journal of clinical oncology.

A Phase III Comparison of Prophylactic Cranial Irradiation versus Observation in Patients with Locally Advanced Non-Small Cell Lung Cancer (RTOG 0214): How to Improve Accrual to an Important Prospective Randomized Study

H. Choy, A. Bezjak, J. Waldron, 2005 .

A phase II trial of pre-operative capecitabine and concurrent radiation for locally advanced rectal cancer

B. Erickson, E. Gore, K. Holen, 2004 .

Technical Note: Is bulk electron density assignment appropriate for MRI‐only based treatment planning for lung cancer?†

Elizabeth Gore, Candice Johnstone, E. Gore, 2017, Medical physics.

Early Assessment of Treatment Responses During Radiation Therapy for Lung Cancer Using Quantitative Analysis of Daily Computed Tomography.

X. Li, J. Paul, E. Gore, 2017, International journal of radiation oncology, biology, physics.

Validation of the performance of the Decipher biopsy genomic classifier in intermediate-risk prostate cancer on the phase III randomized trial NRG Oncology/RTOG 0126.

P. Tran, É. Vigneault, F. Feng, 2022, Journal of Clinical Oncology.

Impact of Incidental Cardiac Radiation on Cardiopulmonary Toxicity and Survival for Locally Advanced Non-Small Cell Lung Cancer: Reanalysis of NRG Oncology/RTOG 0617 With Centrally Contoured Cardiac Structures

P. Iyengar, J. Welsh, J. Bradley, 2016 .

RTOG 0229: A Phase II Trial of Neoadjuvant Therapy with Concurrent Chemotherapy and Full Dose Radiotherapy (XRT) followed by Resection and Consolidative Therapy for LA-NSCLC

H. Choy, M. Suntharalingam, M. Edelman, 2010 .

Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative.

David E Morris, Joel E Tepper, Mack Roach, 2005, International journal of radiation oncology, biology, physics.

Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213.

Benjamin Movsas, Hak Choy, Kyounghwa Bae, 2011, Clinical lung cancer.

A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: Initial analysis of Radiation Therapy Oncology Group 0214.

H. Choy, L. Gaspar, K. Bae, 2009, Journal of Clinical Oncology.

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer

A. Banerjee, E. Gore, D. Johnstone, 2023, Cancers.

Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer.

M. Bousamra, E. Gore, R. Byhardt, 2002, International journal of radiation oncology, biology, physics.

Technical and dosimetric aspects of respiratory gating using a pressure-sensor motion monitoring system.

X Allen Li, Christopher Stepaniak, Elizabeth Gore, 2005, Medical physics.

P-603 Phase I results of RTOG L-0117; a phase i/II dose intensificationstudy using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC

J. Fowler, R. Govindan, H. Choy, 2005 .

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.

J. Deasy, D. Low, H. Sandler, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

NRG Oncology/RTOG 0937: Randomized Phase 2 Study Comparing Prophylactic Cranial Irradiation (PCI) Alone to PCI and Consolidative Extracranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC)

R. Hales, P. Iyengar, J. Bradley, 2016 .

Phase III Study of Prophylactic Cranial Irradiation vs. Observation in Patients with Stage III Non–small-cell Lung Cancer: Neurocognitive and Quality of Life Analysis of RTOG 0214

H. Choy, L. Gaspar, K. Bae, 2009 .

Inferior Clinical Outcomes for Patients With Positive Post-Radiation Therapy Prostate Biopsy: Results From Prospective Randomized Trial RTOG 94-08

Christopher U. Jones, J. Bahary, E. Gore, 2013 .

Radiation Therapy Oncology Group (RTOG) 9408: A Secondary Analysis of the Risk of Death From Second Cancers Comparing Whole Pelvic (WP) Radiation Therapy (RT) to Prostate Only (PO) RT and Neoadjuvant Hormonal Therapy (NHT) + RT to RT Alone

Christopher U. Jones, H. Sandler, M. Roach, 2013 .

Determination of internal target volume for radiation treatment planning of esophageal cancer by using 4-dimensional computed tomography (4DCT).

X. Li, E. Gore, A. Tai, 2014, International journal of radiation oncology, biology, physics.

Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force.

P. Koper, R. Audisio, I. Kunkler, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial

G. Gustafson, D. Yan, H. Sandler, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic classifier performance in intermediate-risk prostate cancer: Results from NRG Oncology/RTOG 0126 randomized phase III trial.

H. Sandler, P. Tran, É. Vigneault, 2023, International journal of radiation oncology, biology, physics.

W. Curran, R. Komaki, K. Bae, 2012, International journal of radiation oncology, biology, physics.

Value CMR: Towards a Comprehensive, Rapid, Cost-Effective Cardiovascular Magnetic Resonance Imaging

El-Sayed H. Ibrahim, Andrew S. Nencka, Kevin M. Koch, 2020, medRxiv.

Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial.

A. Martinez, H. Sandler, D. Citrin, 2021, International journal of radiation oncology, biology, physics.

Determination of internal target volume for radiation treatment planning of esophageal cancer by using 4-dimensional computed tomography (4DCT).

X. Li, E. Gore, A. Tai, 2014, International journal of radiation oncology, biology, physics.